Brian H. Kushner
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Brian H. Kushner as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03033303 · A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk NeuroblastomaMemorial Sloan Kettering Cancer Center · completed · Neuroblastoma · principal investigator
- Ph1NCT00492167 · Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic NeuroblastomaMemorial Sloan Kettering Cancer Center · completed · Neuroblastoma · principal investigator
- Ph1NCT00450307 · Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed NeuroblastomaMemorial Sloan Kettering Cancer Center · completed · Neuroblastoma · study chair
- Ph2NCT00002466 · Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone CancerMemorial Sloan Kettering Cancer Center · completed · Kidney Cancer, Sarcoma · study chair
- Ph2NCT00072358 · Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With NeuroblastomaMemorial Sloan Kettering Cancer Center · completed · Neuroblastoma · principal investigator
- Ph2NCT00024258 · Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsMemorial Sloan Kettering Cancer Center · completed · Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor · study chair
- Ph2NCT00002515 · Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerMemorial Sloan Kettering Cancer Center · completed · Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Head and Neck Cancer · study chair
- Ph2NCT00002560 · Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced NeuroblastomaMemorial Sloan Kettering Cancer Center · completed · Neuroblastoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA008748 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ALEX MACDONALD · fiscal years 2011 to 2026Named on NCT00024258
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:00 UTC. The ranking covers the 200 most relevant of 39 PubMed records, and a shared surname and initials can bring in a namesake. All 39 on PubMed
- Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.J Clin Oncol · 1996276 citationsRCR 7.6
- 214 citationsRCR 5.6
- Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma.J Clin Oncol · 2001161 citationsRCR 3.3
- Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.J Clin Oncol · 1998153 citationsRCR 3.6
- Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.J Clin Oncol · 1995136 citationsRCR 4.6
- Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.J Clin Oncol · 2003130 citationsRCR 3.2
- 115 citationsRCR 3.1
- 111 citationsRCR 3.7
- Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.Clin Cancer Res · 2014109 citationsRCR 3.1
- Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.J Clin Oncol · 2004107 citationsRCR 2.6